# Revvity, Inc.: financial statements, quarterly

RVTY · NYSE · CIK 31791 · [Technology](/sectors/technology.md) · fiscal year ends Dec 29

Pages: [Overview](/companies/rvty.md) · [Financials](/companies/rvty/financials.md) · [Filings](/companies/rvty/filings.md) · [Insiders](/companies/rvty/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rvty/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [671](/filings/0000031791-24-000028.md) | [696 d](/filings/0000031791-26-000012.md) | [650](/filings/0000031791-25-000015.md) | [692](/filings/0000031791-25-000026.md) | [684](/filings/0000031791-25-000037.md) | [729 d](/filings/0000031791-26-000012.md) | [665](/filings/0000031791-26-000019.md) | [720](/filings/0000031791-26-000027.md) | [699](/filings/0000031791-25-000037.md) | [772 d](/filings/0000031791-26-000012.md) | [711](/filings/0000031791-26-000019.md) | [730](/filings/0000031791-26-000027.md) |
| Cost of revenue | $m | [298](/filings/0000031791-24-000028.md) | not reported | [295](/filings/0000031791-25-000015.md) | [306](/filings/0000031791-25-000026.md) | [299](/filings/0000031791-25-000037.md) | not reported | [289](/filings/0000031791-26-000019.md) | [328](/filings/0000031791-26-000027.md) | [324](/filings/0000031791-25-000037.md) | not reported | [323](/filings/0000031791-26-000019.md) | [313](/filings/0000031791-26-000027.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [53.0](/filings/0000031791-24-000028.md) | [49.6 d](/filings/0000031791-26-000012.md) | [50.4](/filings/0000031791-25-000015.md) | [48.1](/filings/0000031791-25-000026.md) | [49.1](/filings/0000031791-25-000037.md) | [49.2 d](/filings/0000031791-26-000012.md) | [53.6](/filings/0000031791-26-000019.md) | [53.3](/filings/0000031791-26-000027.md) | [50.8](/filings/0000031791-25-000037.md) | [58.2 d](/filings/0000031791-26-000012.md) | [57.9](/filings/0000031791-26-000019.md) | [49.0](/filings/0000031791-26-000027.md) |
| Selling, general and administrative | $m | [250](/filings/0000031791-24-000028.md) | [257 d](/filings/0000031791-26-000012.md) | [261](/filings/0000031791-25-000015.md) | [252](/filings/0000031791-25-000026.md) | [238](/filings/0000031791-25-000037.md) | [244 d](/filings/0000031791-26-000012.md) | [250](/filings/0000031791-26-000019.md) | [249](/filings/0000031791-26-000027.md) | [242](/filings/0000031791-25-000037.md) | [252 d](/filings/0000031791-26-000012.md) | [254](/filings/0000031791-26-000019.md) | [279](/filings/0000031791-26-000027.md) |
| Operating income | $m | [69.2](/filings/0000031791-24-000028.md) | [77.2 d](/filings/0000031791-26-000012.md) | [44.1](/filings/0000031791-25-000015.md) | [85.7](/filings/0000031791-25-000026.md) | [98.2](/filings/0000031791-25-000037.md) | [119 d](/filings/0000031791-26-000012.md) | [72.2](/filings/0000031791-26-000019.md) | [90.8](/filings/0000031791-26-000027.md) | [81.9](/filings/0000031791-25-000037.md) | [112 d](/filings/0000031791-26-000012.md) | [75.9](/filings/0000031791-26-000019.md) | [89.3](/filings/0000031791-26-000027.md) |
| Interest expense | $m | [25.5](/filings/0000031791-23-000014.md) | [24.6 d](/filings/0000031791-26-000012.md) | [24.4](/filings/0000031791-24-000014.md) | [24.7](/filings/0000031791-24-000021.md) | [24.4](/filings/0000031791-25-000037.md) | [22.8 d](/filings/0000031791-26-000012.md) | [23.0](/filings/0000031791-26-000019.md) | [22.9](/filings/0000031791-26-000027.md) | [22.8](/filings/0000031791-25-000037.md) | [23.5 d](/filings/0000031791-26-000012.md) | [24.7](/filings/0000031791-26-000019.md) | [23.0](/filings/0000031791-26-000027.md) |
| Income tax | $m | [18.1](/filings/0000031791-24-000028.md) | [(32.2) d](/filings/0000031791-26-000012.md) | [5.9](/filings/0000031791-25-000015.md) | [14.1](/filings/0000031791-25-000026.md) | [7.0](/filings/0000031791-25-000037.md) | [6.2 d](/filings/0000031791-26-000012.md) | [10.7](/filings/0000031791-26-000019.md) | [13.4](/filings/0000031791-26-000027.md) | [8.5](/filings/0000031791-25-000037.md) | [(4.2) d](/filings/0000031791-26-000012.md) | [9.1](/filings/0000031791-26-000019.md) | [10.1](/filings/0000031791-26-000027.md) |
| Net income | $m | [9.5](/filings/0000031791-24-000028.md) | [78.6 d](/filings/0000031791-26-000012.md) | [26.0](/filings/0000031791-25-000037.md) | [55.4](/filings/0000031791-25-000037.md) | [94.4](/filings/0000031791-25-000037.md) | [94.6 d](/filings/0000031791-26-000012.md) | [42.2](/filings/0000031791-26-000027.md) | [53.9](/filings/0000031791-26-000027.md) | [46.7](/filings/0000031791-25-000037.md) | [98.4 d](/filings/0000031791-26-000012.md) | [40.7](/filings/0000031791-26-000027.md) | [51.8](/filings/0000031791-26-000027.md) |
| Diluted EPS | $ per share | [0.08](/filings/0000031791-24-000028.md) | not reported | [0.21](/filings/0000031791-25-000015.md) | [0.45](/filings/0000031791-25-000026.md) | [0.77](/filings/0000031791-25-000037.md) | not reported | [0.35](/filings/0000031791-26-000019.md) | [0.46](/filings/0000031791-26-000027.md) | [0.40](/filings/0000031791-25-000037.md) | not reported | [0.36](/filings/0000031791-26-000019.md) | [0.47](/filings/0000031791-26-000027.md) |
| Basic EPS | $ per share | [0.08](/filings/0000031791-24-000028.md) | not reported | [0.21](/filings/0000031791-25-000015.md) | [0.45](/filings/0000031791-25-000026.md) | [0.77](/filings/0000031791-25-000037.md) | not reported | [0.35](/filings/0000031791-26-000019.md) | [0.46](/filings/0000031791-26-000027.md) | [0.40](/filings/0000031791-25-000037.md) | not reported | [0.36](/filings/0000031791-26-000019.md) | [0.47](/filings/0000031791-26-000027.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-01) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-28) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.1](/filings/0000031791-24-000028.md) | [0.9](/filings/0000031791-26-000012.md) | [1.0](/filings/0000031791-25-000015.md) | [1.2](/filings/0000031791-25-000026.md) | [1.2](/filings/0000031791-25-000037.md) | [1.2](/filings/0000031791-26-000012.md) | [1.1](/filings/0000031791-26-000019.md) | [1.0](/filings/0000031791-26-000027.md) | [0.9](/filings/0000031791-25-000037.md) | [0.9](/filings/0000031791-26-000027.md) | [0.9](/filings/0000031791-26-000019.md) | [1.0](/filings/0000031791-26-000027.md) |
| Current assets | $bn | [2.9](/filings/0000031791-23-000014.md) | [3.0](/filings/0000031791-25-000009.md) | [3.1](/filings/0000031791-24-000014.md) | [3.2](/filings/0000031791-24-000021.md) | [2.4](/filings/0000031791-24-000028.md) | [2.3](/filings/0000031791-26-000012.md) | [2.3](/filings/0000031791-25-000015.md) | [2.2](/filings/0000031791-25-000026.md) | [2.1](/filings/0000031791-25-000037.md) | [2.2](/filings/0000031791-26-000027.md) | [2.1](/filings/0000031791-26-000019.md) | [2.3](/filings/0000031791-26-000027.md) |
| Total assets | $bn | [13.4](/filings/0000031791-23-000014.md) | [13.6](/filings/0000031791-25-000009.md) | [13.4](/filings/0000031791-24-000014.md) | [13.4](/filings/0000031791-24-000021.md) | [12.8](/filings/0000031791-24-000028.md) | [12.4](/filings/0000031791-26-000012.md) | [12.4](/filings/0000031791-25-000015.md) | [12.4](/filings/0000031791-25-000026.md) | [12.1](/filings/0000031791-25-000037.md) | [12.2](/filings/0000031791-26-000027.md) | [12.0](/filings/0000031791-26-000019.md) | [12.0](/filings/0000031791-26-000027.md) |
| Current liabilities | $bn | [1.4](/filings/0000031791-23-000014.md) | [1.5](/filings/0000031791-25-000009.md) | [1.4](/filings/0000031791-24-000014.md) | [1.4](/filings/0000031791-24-000021.md) | [0.7](/filings/0000031791-24-000028.md) | [0.7](/filings/0000031791-26-000012.md) | [0.6](/filings/0000031791-25-000015.md) | [0.7](/filings/0000031791-25-000026.md) | [1.2](/filings/0000031791-25-000037.md) | [1.3](/filings/0000031791-26-000027.md) | [1.2](/filings/0000031791-26-000019.md) | [1.3](/filings/0000031791-26-000027.md) |
| Total liabilities | $bn | [5.7](/filings/0000031791-23-000014.md) | [5.7](/filings/0000031791-25-000009.md) | [5.6](/filings/0000031791-24-000014.md) | [5.6](/filings/0000031791-24-000021.md) | [4.8](/filings/0000031791-24-000028.md) | [4.7](/filings/0000031791-26-000012.md) | [4.7](/filings/0000031791-25-000015.md) | [4.8](/filings/0000031791-25-000026.md) | [4.8](/filings/0000031791-25-000037.md) | [4.9](/filings/0000031791-26-000027.md) | [4.8](/filings/0000031791-26-000019.md) | [4.8](/filings/0000031791-26-000027.md) |
| Long-term debt | $bn | [3.2](/filings/0000031791-23-000014.md) | [3.2](/filings/0000031791-25-000009.md) | [3.2](/filings/0000031791-24-000014.md) | [3.2](/filings/0000031791-24-000021.md) | [3.2](/filings/0000031791-24-000028.md) | [3.2](/filings/0000031791-26-000012.md) | [3.2](/filings/0000031791-25-000015.md) | [3.2](/filings/0000031791-25-000026.md) | [2.6](/filings/0000031791-25-000037.md) | [2.6](/filings/0000031791-26-000027.md) | [2.6](/filings/0000031791-26-000019.md) | [2.6](/filings/0000031791-26-000027.md) |
| Current portion of debt | $bn | [0.7](/filings/0000031791-23-000014.md) | [0.7](/filings/0000031791-25-000009.md) | [0.7](/filings/0000031791-24-000014.md) | [0.7](/filings/0000031791-24-000021.md) | [0.0](/filings/0000031791-24-000028.md) | [0.0](/filings/0000031791-26-000012.md) | [0.0](/filings/0000031791-25-000015.md) | [0.0](/filings/0000031791-25-000026.md) | [0.6](/filings/0000031791-25-000037.md) | [0.6](/filings/0000031791-26-000027.md) | [0.6](/filings/0000031791-26-000019.md) | [0.6](/filings/0000031791-26-000027.md) |
| Shareholders' equity | $bn | [7.7](/filings/0000031791-24-000028.md) | [7.9](/filings/0000031791-26-000012.md) | [7.8](/filings/0000031791-25-000037.md) | [7.9](/filings/0000031791-25-000037.md) | [7.9](/filings/0000031791-25-000037.md) | [7.7](/filings/0000031791-26-000027.md) | [7.6](/filings/0000031791-26-000027.md) | [7.6](/filings/0000031791-26-000027.md) | [7.4](/filings/0000031791-25-000037.md) | [7.3](/filings/0000031791-26-000027.md) | [7.2](/filings/0000031791-26-000027.md) | [7.2](/filings/0000031791-26-000027.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(33.5) d](/filings/0000031791-24-000028.md) | [197 d](/filings/0000031791-26-000012.md) | [148](/filings/0000031791-25-000015.md) | [159 d](/filings/0000031791-25-000026.md) | [148 d](/filings/0000031791-25-000037.md) | [174 d](/filings/0000031791-26-000012.md) | [128](/filings/0000031791-26-000019.md) | [134 d](/filings/0000031791-26-000027.md) | [139 d](/filings/0000031791-25-000037.md) | [182 d](/filings/0000031791-26-000012.md) | [115](/filings/0000031791-26-000019.md) | [192 d](/filings/0000031791-26-000027.md) |
| Capital expenditure | $m | [22.4 d](/filings/0000031791-24-000028.md) | [24.1 d](/filings/0000031791-26-000012.md) | [17.8](/filings/0000031791-25-000015.md) | [22.0 d](/filings/0000031791-25-000026.md) | [22.3 d](/filings/0000031791-25-000037.md) | [24.5 d](/filings/0000031791-26-000012.md) | [16.0](/filings/0000031791-26-000019.md) | [18.9 d](/filings/0000031791-26-000027.md) | [18.5 d](/filings/0000031791-25-000037.md) | [20.2 d](/filings/0000031791-26-000012.md) | [19.8](/filings/0000031791-26-000019.md) | [11.1 d](/filings/0000031791-26-000027.md) |
| Dividends paid | $m | [8.7 d](/filings/0000031791-24-000028.md) | [8.6 d](/filings/0000031791-26-000012.md) | [8.6](/filings/0000031791-25-000015.md) | [8.6 d](/filings/0000031791-25-000026.md) | [8.6 d](/filings/0000031791-25-000037.md) | [8.5 d](/filings/0000031791-26-000012.md) | [8.4](/filings/0000031791-26-000019.md) | [8.3 d](/filings/0000031791-26-000027.md) | [8.1 d](/filings/0000031791-25-000037.md) | [8.0 d](/filings/0000031791-26-000012.md) | [7.8](/filings/0000031791-26-000019.md) | [7.8 d](/filings/0000031791-26-000027.md) |
| Share repurchases | $m | [111 d](/filings/0000031791-24-000028.md) | [4.9 d](/filings/0000031791-26-000012.md) | [10.8](/filings/0000031791-25-000015.md) | [19.6 d](/filings/0000031791-25-000026.md) | [154 d](/filings/0000031791-25-000037.md) | [185 d](/filings/0000031791-26-000012.md) | [154](/filings/0000031791-26-000019.md) | [294 d](/filings/0000031791-26-000027.md) | [205 d](/filings/0000031791-25-000037.md) | [168 d](/filings/0000031791-26-000012.md) | [86.5](/filings/0000031791-26-000019.md) | [16.0 d](/filings/0000031791-26-000027.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-02) | Q1 FY2023 (2023-04-02) | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [127](/filings/0000031791-23-000014.md) | [126](/filings/0000031791-24-000014.md) | [125](/filings/0000031791-24-000021.md) | [124](/filings/0000031791-24-000028.md) | [124](/filings/0000031791-25-000015.md) | [123](/filings/0000031791-25-000026.md) | [123](/filings/0000031791-25-000037.md) | [120](/filings/0000031791-26-000019.md) | [118](/filings/0000031791-26-000027.md) | [115](/filings/0000031791-25-000037.md) | [112](/filings/0000031791-26-000019.md) | [112](/filings/0000031791-26-000027.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 111,586,401 at 2026-08-06, from the cover of the [10-Q filed 2026-08-11](/filings/0000031791-26-000027.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.